Loading…
Employees: 15,933
Size Shu Yu Civilian Pharmacy (301017.SZ) is a China Consumer Staples company (Drugstore Chains) with a market value of $872M, the 2572nd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥14.34 on 6 Nov 2026.
Performance Over six months the shares gained 9.4%, against -2.4% for the median peer and -16.4% for the China market (cap-weighted) — 4th highest of 18 in its peer set.
Growth Revenue grew 9.2% over the last twelve months (peer median +6.7%); the operating margin is 1.9% (peer median 4.7%).
Valuation It trades at 0.9× enterprise value to sales against a peer median of 0.6× (7th most expensive of 18).
Price implies For today's price to make sense, revenue must grow about 4% a year for seven years (Req g). Recent delivered growth is +17%, so the hurdle is -13 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 1.0 points above its cost of capital (5.7% WACC).
Next results Next results expected around 5 May 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥10.9B | CN¥10.3B | CN¥9.55B | CN¥9.17B | CN¥7.81B |
| Revenue growth | — | +8% | +4% | +17% | — |
| Gross profit | CN¥3.11B | CN¥2.62B | CN¥2.32B | CN¥2.50B | CN¥2.16B |
| EBITDA | n/a | CN¥616M | CN¥571M | CN¥854M | CN¥800M |
| Net income | CN¥26.9M | CN¥114M | -CN¥189M | CN¥133M | CN¥229M |
| Free cash flow | CN¥464M | CN¥634M | CN¥318M | -CN¥33.4M | CN¥43.9M |
| Capital expenditure | CN¥83.7M | CN¥172M | CN¥174M | CN¥182M | CN¥110M |
| Total debt | CN¥5.12B | CN¥5.06B | CN¥5.31B | CN¥5.31B | CN¥4.05B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301017.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -0.2% | +1.9% | 9th lowest of 18 |
| 6-month return | +9.4% | -2.4% | 4th highest of 18 |
| Distance from 52-week high | -37.7% | -32.0% | 8th lowest of 18 |
| Revenue growth (TTM) | +9.2% | +6.7% | 6th highest of 18 |
| Operating margin | 1.9% | 4.7% | 4th lowest of 18 |
| EV / Sales | 0.9× | 0.6× | 7th most expensive of 18 |
| Growth the price implies (Req g, 7 yrs) | 4.0% | -6.5% | 5th most demanding of 16 |
| Growth delivered (Del g) | +17.4% | +9.7% | 3rd highest of 16 |
| Hurdle (Req g minus delivered) | -13.4 pp | -19.5 pp | 7th most demanding of 16 |
| ROIC minus cost of capital | +1.0 pp | +2.8 pp | 7th lowest of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shu Yu Civilian Pharmacy 301017.SZ | China | $872M | +9% | +9% | 2% | 0.9× | 4.0% | +17.4% |
| Anhui Huaren Health Pharmaceutical 301408.SZ | China | $829M | -35% | +15% | 8% | 1.2× | -6.0% | +23.3% |
| MedPlus Health Services MEDPLUS.NS | India | $769M | -31% | +21% | 4% | 1.1× | 18.5% | +17.6% |
| Genky DrugStores 9267.T | Japan | $723M | +3% | +8% | 5% | 0.6× | n/a | n/a |
| Yixintang Pharmaceutical 002727.SZ | China | $1.18B | +6% | -2% | 3% | 0.5× | -15.9% | +6.5% |
| Ain 9627.T | Japan | $1.23B | -2% | +42% | 4% | 0.4× | -6.5% | +16.9% |
| Beijing Konruns Pharmaceutical 603590.SS | China | $617M | -28% | +4% | 20% | 4.2× | 11.6% | +2.7% |
| Create SD 3148.T | Japan | $1.30B | -2% | +9% | 5% | 0.3× | -11.5% | +8.0% |
| Cawachi 2664.T | Japan | $577M | +37% | -1% | 2% | 0.2× | -5.8% | 0.0% |
| Qol 3034.T | Japan | $567M | +38% | +7% | 6% | 0.4× | -16.2% | +12.4% |
| Luyan Pharma 002788.SZ | China | $555M | -30% | +3% | 3% | 0.5× | 0.1% | +6.5% |
| LBX Pharmacy Chain Joint Stock 603883.SS | China | $1.69B | +7% | +3% | 5% | 0.8× | -10.9% | +9.7% |
| Landfar Bio-medicine 000504.SZ | China | $395M | -16% | +497% | -2% | 3.5× | n/a | n/a |
| Shanghai No. 1 Pharmacy 600833.SS | China | $314M | -24% | +1% | -1% | 0.9× | 20.4% | +6.1% |
| JZJ Chain Drugstore Corporation 605266.SS | China | $307M | -34% | -5% | 0% | 0.8× | -9.6% | +14.8% |
| Guardian Pharmacy Services GRDN | United States | $2.68B | +17% | +10% | 6% | 1.8× | 4.1% | +16.8% |
| Sundrug 9989.T | Japan | $2.77B | -1% | +4% | 5% | 0.5× | -8.0% | +5.8% |
| Sugi 7649.T | Japan | $3.27B | -23% | +9% | 5% | 0.5× | -9.7% | +10.9% |